Property:Outcome timeline
This is a property of type Text.
K
Kessels et al. (2017): Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma A Randomized Clinical Trial +
T0: Baseline
T1: after 3 weeks
T2: after 6 weeks
T3: after 8 weeks (directly before operation) +
Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial +
T0: Baseline
T1: at week 12
T2: at week 24 +
Khodabakhshi et al. (2019): Feasibility, Safety, and Beneficial Effects of MCT-Based Ketogenic Diet for Breast Cancer Treatment: A Randomized Controlled Trial Study +
T0: Baseline
T1: 3rd visit (after about 9 weeks)
T2: after 3 months +
Kirste et al. (2011): Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial +
T0: Baseline at the beginning of radiotherapy,
T1: At the end of radiotherapy,
Follow-up: After 4 weeks end of radiotherapy +
Konmun et al. (2017): A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy +
T1: Day 1 (i.e. first day of chemotherapy administration)
T2: Day 2
T3: Day 3
T4: Day 4
T5: Day 5
T6: Day 22
T7: Day 43
T8: Day 64 +
Kottschade et al. (2011): The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial +
Baseline, before each chemotherapy, 1 month and 6 months post-chemotherapy +
Koyama et al. (2017): Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients +
T0: preoperative phase
T1: 1 day after surgery
T2-T7: Day 2-7 after surgery
Blood samples at T0, T1, T3 and T4; carnitine concentration at T0, T1, T3, T7; C-reactive protein (CRP) at T3 and T7, urine samples at T3 and T7 +
Kraft et al. (2012): L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial +
T0: Baseline before intervention
T1: 6 weeks after intervention
T2: 12 weeks after intervention +
L
Laali et al. (2020): Effect of Selenium on Incidence and Severity of Mucositis during Radiotherapy in Patients with Head and Neck Cancer +
Oral mucositis
T0: Baseline
Follow up: weekly for 7 weeks
Selenium level
T0: Baseline
T1: End of radiation +
Li et al. (2018): Efficacy of Ginger in Ameliorating Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Among Patients With Lung Cancer Receiving Cisplatin-Based Regimens: A Randomized Controlled Trial +
T0: Baseline
T1: Acute symptoms 2 days after chemotherapy
T2: 5 days after chemotherapy +
Lian et al. (2014): Comparing the Effectiveness of Green Tea versus Topical Metronidazole Powder in Malodorous Control of Fungating Malignant Wounds in a Controlled Randomised Study +
T0: Baseline
T1: after 7 days +
Lichtmann et al. (2018): Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain +
T0: baseline
T1: after 3 weeks (21 days)
T2: after 5 weeks (35 days)
T3: after 7 weeks follow-up (up to day 43) +
Lin et al. (2006): Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study +
T0: before radiotherapy
T1: after radiotherapy
1st Follow-Up at 3 months after radiotherapy
2nd Follow-Up at 12 months after radiotherapy +
Lin et al. (2008): Effects of zinc supplementation on clinical outcomes in patients receiving radiotherapy for head and neck cancers: a double-blinded randomized study +
T0: after radiotherapy
Follow-Up: every 3 months after therapy +
Lin et al. (2009): Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow-up of a double-blind randomized study with subgroup analysis +
Follow-up period of 5 years (followed up on once a month during the first year of study and then every 3 months thereafter) +
Lin et al. (2010): Discrepancy of the effects of zinc supplementation on the prevention of radiotherapy-induced mucositis between patients with nasopharyngeal carcinoma and those with oral cancers: subgroup analysis of a double-blind, randomized study +
T0: before radiotherapy
1st Follow-Up at 3 months after radiotherapy
2nd Follow-Up at 12 months after radiotherapy +
Lissoni et al. (1998): Biotherapy with the Pineal Immunomodulating Hormone Melatonin versus Melatonin plus Aloe vera in Untreatable Advanced Solid Neoplasms +
T0: baseline
T1: 2-month-intervals until progression of diasease
Follow-up: after 1 year +
Lissoni et al. (2009): A Randomized Study of Chemotherapy versus Biochemotherapy with Chemotherapy plus Aloe arborescens in Patients with Metastatic Cancer +
T0: Baseline
T1: weekly until progression of diasease
Follow-up: after 3 years +
Liu et al. (2010): Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial +
A: 1 hour after ingestion of 131I
B: 5 hours after ingestion of 131I
C: 13 hours after ingestion of 131I
D: 25 hours after ingestion of 131I +
Lua et al. (2015): Effects of inhaled ginger aromatherapy on chemotherapy-induced nausea and vomiting and health-related quality of life in women with breast cancer +
T0: Baseline (before chemotherapy)
T1: Day 1 (day of chemotherapy)
T2: Day 2
T3: Day 3
T4: Day 4
T5: Day 5
T6: Day 8 +